1. Leptomeningeal Gliomatosis: A Single Institution Study of 31 Patients
- Author
-
Dominique Figarella-Branger, Romain Appay, Celine Boucard, Emeline Tabouret, Chantal Campello, Maryline Barrie, Anderson Loundou, Colette Monserrat, Olivier Chinot, Didier Autran, Henry Dufour, Thomas Graillon, Gregorio Petrirena, Laetitia Padovani, and Mona Matta
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,medicine.medical_treatment ,Immunoglobulin D ,Gastroenterology ,Disease-Free Survival ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Glioma ,Antineoplastic Combined Chemotherapy Protocols ,Meningeal Neoplasms ,Temozolomide ,medicine ,Humans ,Karnofsky Performance Status ,Single institution ,Aged ,Retrospective Studies ,Univariate analysis ,Chemotherapy ,biology ,Brain Neoplasms ,business.industry ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,Carmustine ,Combined Modality Therapy ,Neoplasms, Neuroepithelial ,Confidence interval ,Treatment Outcome ,Oncology ,030220 oncology & carcinogenesis ,Multivariate Analysis ,biology.protein ,Female ,business ,medicine.drug - Abstract
BACKGROUND/AIM Secondary leptomeningeal gliomatosis (LG) is a rare and severe progression pattern of glioma. Our objective was to evaluate the characteristics and outcome of patients with LG. PATIENTS AND METHODS We retrospectively reviewed 31 patients diagnosed with secondary LG. At the time of LG diagnosis, the median age of patients was 45 years. The histological grade was IV in 20 patients and II to III in 11 patients. As a first-line of therapy for LG, 22 patients received an oncological treatment: i) BCNU-temozolomide (TMZ) (n=15), ii) other type of chemotherapy (n=7), and iii) no treatment (supportive care) (n=9). RESULTS Following LG diagnosis, the median progression-free survival (PFS) and overall survival (OS) were 1.8 months [95% confidence interval (CI)=0.9-2.7] and 2.1 months (95%CI=1.3-3), respectively. The univariate analyses showed an improved OS with age of less than 45 years (p
- Published
- 2019